Nov 15, 2022 / 02:40PM GMT
Matthew Charles Taylor - Jefferies LLC, Research Division - Equity Analyst
Matt Taylor, Jefferies analyst here with Teleflex, Liam Kelly, CEO; Larry Keusch, who heads the IR function; and John Hsu also in IR in the audience.
We've scheduled 30 minutes because of the weather, we're only going to do 10. I really wanted to turn up the heat on these guys. So just the hard-hitting questions from here out. Anyway, so we always start high level. So maybe just for folks that don't know, talk about Teleflex's strategy, how you've kind of constructed the portfolio, talk about some of the bits and pieces that you've put together to create some of these focus areas. And then what that does for your long-term growth and margin plans.
Liam J. Kelly - Teleflex Incorporated - Chairman, President & CEO
Yes. So we started with a core group of products within Teleflex. We began our journey in 2011. We were a diversified med tech company, and we became a pure-play medical device company.
Back then, our growth rate was anything from minus 1% to plus 1%. Gross
Teleflex Inc at Jefferies London Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers